GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Waters WAT · USD

Health Care · Life Sciences Tools & Services · US listing · 🇺🇸 United States

S&P 500

Compare

456.48

-2.06%

Close of 19 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Waters — daily WAT Delayed
Market value
$34.14bn
Last close × shares
Volume
1m
Shares, 19 Nov 2026
Price to earnings
43.4

About Waters

From its filings with the US Securities and Exchange Commission

SEC filings

Waters is based in Milford, Massachusetts and is incorporated in Delaware. Its shares trade on NYSE under the ticker WAT. It is a member of the S&P 500. The SEC classifies its business as laboratory analytical instruments. In the fiscal year to 31 December 2025, it reported revenue of $3.17bn and net income of $642.6m. At that date it held total assets of $5.08bn and shareholders' equity of $2.56bn.

In its own words

Waters Corporation (the “Company,” “we,” “our,” or “us”), a global leader in analytical instruments and software, has pioneered innovations in chromatography, mass spectrometry and thermal analysis serving life, materials and food sciences for more than 65 years. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (“HPLC”), ultra-performance liquid chromatography (“UPLC” and together with HPLC, referred to as “LC”) and mass spectrometry (“MS”) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. These systems are complementary products that are frequently employed together (“LC-MS”) and sold as integrated instrument systems using common software platforms.

The Company’s products are used by pharmaceutical, clinical, biochemical, industrial, nutritional safety, environmental, academic and governmental customers working in research and development, quality assurance and other laboratory applications. LC is a standard technique and is utilized in a broad range of industries to detect, identify, monitor and measure the chemical, physical and biological composition of materials, and to purify a full range of compounds. MS technology, principally in conjunction with chromatography, is employed in drug discovery and development, including clinical trial testing, the analysis of proteins in disease processes (known as “proteomics”), nutritional safety analysis and environmental testing.

Quoted from its 10-K, filed 23 Feb 2026. Read the filing on SEC.gov ↗

More about Waters →

How it makes its money

Revenue, year to 31 Dec 2025

  • Product [Member] $1.98bn · 62.5%
  • Instrument Systems [Member] $1.35bn · 42.5%
  • Waters Instrument Systems [Member] $1.10bn · 34.8%
  • Waters Service [Member] $1.08bn · 34.1%

Latest on Waters

Our reporting

Next results

8 Feb 2027

Due on 8 Feb 2027. Analysts expect earnings of 4.63 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Waters's ticker?

Waters trades as WAT on its US listing, under ISIN US9418481035.

What was Waters's last closing price?

456.48 on 19 Nov 2026. The figure is in USD and is never converted.

When does Waters next report results?

Results are expected on 8 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
SEC filings and our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.